Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bacterial Infections and Mycoses

Free Subscription Articles published in Am J Respir Crit Care Med Retrieve available abstracts of 65 articles: HTML format

Single Articles

April 2024
1. GAUSI K, Ignatius EH, De Jager V, Upton C, et al
   High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.
   Am J Respir Crit Care Med. 2024 Apr 2. doi: 10.1164/rccm.202311-2004.
   PubMed     Abstract available
   
   
   
2. ZHANG M, Luo Q, Li X, Mu X, et al
   Pulmonary Artery Pseudoaneurysm Caused by Pulmonary Mucormycosis.
   Am J Respir Crit Care Med. 2024;209:879-880.
   PubMed    
   
   
   March 2024
3. AHMAD S, Wrennall JA, Goriounova AS, Sekhri M, et al
   Specific Inhibition of Orai1-mediated Calcium Signalling Resolves Inflammation and Clears Bacteria in an Acute Respiratory Distress Syndrome Model.
   Am J Respir Crit Care Med. 2024;209:703-715.
   PubMed     Abstract available
   
   
   February 2024
4. TREVISI L, Brooks MB, Becerra MC, Calderon RI, et al
   Who Transmits Tuberculosis to Whom: A Cross-Sectional Analysis of a Cohort Study in Lima, Peru.
   Am J Respir Crit Care Med. 2024 Feb 28. doi: 10.1164/rccm.202307-1217.
   PubMed     Abstract available
   
   
   
5. LIN CF, Wu YW, Liao WA, Lin CY, et al
   Right Atrial Angiosarcoma with Embolic Lung Metastases Masquerading as Atypical Pneumonitis.
   Am J Respir Crit Care Med. 2024;209:325-328.
   PubMed    
   
   
   
6. XIA L, Hantrakun V, Teparrukkul P, Wongsuvan G, et al
   Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.
   Am J Respir Crit Care Med. 2024;209:288-298.
   PubMed     Abstract available
   
   
   January 2024
7. LAGHLAM D, Giraud F, Benghanem S
   Severe Pulmonary and Nasopharyngeal Candida Krusei Infection in Cocaine-induced Vasculopathy.
   Am J Respir Crit Care Med. 2024 Jan 11. doi: 10.1164/rccm.202305-0828.
   PubMed    
   
   
   December 2023
8. TSIN WEN Y, Cheng AC, Podin Y
   Precision Medicine for Sepsis Management in Low- and Middle-Income Countries - Melioidosis as a Model?
   Am J Respir Crit Care Med. 2023 Dec 6. doi: 10.1164/rccm.202311-2056.
   PubMed    
   
   
   
9. NATHANI A, Tauquir A, Khan S, Arrossi AV, et al
   Unusual Presentation of Pneumocystis jirovecii Pneumonia in an Immunocompromised Host.
   Am J Respir Crit Care Med. 2023;208:e44-e46.
   PubMed    
   
   
   November 2023
10. FEYS S, Hoenigl M, Gangneux JP MD, PhD, FECMM, Verweij PE, et al
    Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research.
    Am J Respir Crit Care Med. 2023 Nov 16. doi: 10.1164/rccm.202310-1815.
    PubMed    
    
    
    
11. LONG DR, Holmes EA, Goss CH, Singh PK, et al
    Cell-Free DNA Detects Pseudomonas aeruginosa Lung Infection in Modulator-treated People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2023;208:944-947.
    PubMed    
    
    
    October 2023
12. ANIDI IU, Kirenga B, Fennelly KP
    Pulmonary Rehabilitation for Post-Tuberculosis Lung Disease.
    Am J Respir Crit Care Med. 2023 Oct 5. doi: 10.1164/rccm.202309-1571.
    PubMed    
    
    
    
13. ROCHESTER CL, Alison JA, Carlin B, Holland AE, et al
    Reply to: Pulmonary Rehabilitation for Post-Tuberculosis Lung Disease.
    Am J Respir Crit Care Med. 2023 Oct 5. doi: 10.1164/rccm.202309-1714.
    PubMed    
    
    
    
14. SAEKI Y, Moriyama Y, Araki Y, Oda A, et al
    Gas Gangrene after Thoracic Drainage for Empyema with Tension Pneumothorax.
    Am J Respir Crit Care Med. 2023;208:814-815.
    PubMed    
    
    
    August 2023
15. HILL H, Mitsi E, Nikolaou E, Blizard A, et al
    A Randomised Controlled Trial of Nasal Immunisation with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection Challenge.
    Am J Respir Crit Care Med. 2023 Aug 9. doi: 10.1164/rccm.202302-0222.
    PubMed     Abstract available
    
    
    July 2023
16. OTTEWILL C, Dolan L, Lopez Bailen E, Roycroft E, et al
    Immunosuppressed Pets as a Conduit for Zoonotic Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jul 25. doi: 10.1164/rccm.202304-0734.
    PubMed    
    
    
    June 2023
17. ALBRICH WC, Lamoth F
    Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization Versus Infection?
    Am J Respir Crit Care Med. 2023 Jun 22. doi: 10.1164/rccm.202306-1022.
    PubMed    
    
    
    
18. VANDERBEKE L, Jacobs C, Feys S, Resendiz-Sharpe A, et al
    A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
    Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202208-1570.
    PubMed     Abstract available
    
    
    
19. PATANKAR S, Cruz AT, Douglas-Jones B, Garcia-Prats A, et al
    Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jun 5. doi: 10.1164/rccm.202304-0670.
    PubMed    
    
    
    
20. BRUST JCM
    "Weighting" the Evidence: How Much Bedaquiline Is Enough?
    Am J Respir Crit Care Med. 2023;207:1423-1424.
    PubMed    
    
    
    May 2023
21. MITNICK CD, Nunn AJ
    Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
    Am J Respir Crit Care Med. 2023;207:1269-1270.
    PubMed    
    
    
    
22. KURBATOVA EV, Phillips PPJ, Dorman SE, Sizemore EE, et al
    A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
    Am J Respir Crit Care Med. 2023;207:1376-1382.
    PubMed     Abstract available
    
    
    
23. LIU Y, Xu J, Wang C, Lu B, et al
    Pulmonary Mucormycosis with Rib Involvement in an Immunocompromised Patient.
    Am J Respir Crit Care Med. 2023;207:1393-1394.
    PubMed    
    
    
    April 2023
24. BORGES DE ALMEIDA CP, Mitnick CD
    Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management.
    Am J Respir Crit Care Med. 2023 Apr 19. doi: 10.1164/rccm.202303-0601.
    PubMed    
    
    
    
25. MARTINEZ L, Zar HJ
    Reply to: Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management.
    Am J Respir Crit Care Med. 2023 Apr 19. doi: 10.1164/rccm.202304-0629.
    PubMed    
    
    
    
26. MASEKELA R, Mandalakas AM
    Pediatric Post-TB Lung Disease: Ready for Prime Time?
    Am J Respir Crit Care Med. 2023;207:975-977.
    PubMed    
    
    
    February 2023
27. TREVISI L, Hernan MA, Mitnick CD, Khan U, et al
    Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
    Am J Respir Crit Care Med. 2023 Feb 21. doi: 10.1164/rccm.202211-2125.
    PubMed     Abstract available
    
    
    
28. MARTINEZ L, Gray DM, Botha M, Nel M, et al
    The Long-Term Impact of Early-Life Tuberculosis Disease on Child Health: A Prospective Birth Cohort Study.
    Am J Respir Crit Care Med. 2023 Feb 6. doi: 10.1164/rccm.202208-1543.
    PubMed     Abstract available
    
    
    January 2023
29. STAGG HR, Thompson JA, Lipman MCI, Sloan DJ, et al
    Forgiveness Is the Attribute of the Strong: Nonadherence and Regimen Shortening in Drug-sensitive Tuberculosis.
    Am J Respir Crit Care Med. 2023;207:193-205.
    PubMed     Abstract available
    
    
    
30. VELASQUEZ GE, Nahid P
    Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-Susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2262.
    PubMed    
    
    
    December 2022
31. DOOLEY KE, Hendricks B, Gupte N, Barnes G, et al
    Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results.
    Am J Respir Crit Care Med. 2022 Dec 1. doi: 10.1164/rccm.202208-1475.
    PubMed     Abstract available
    
    
    
32. 
    Erratum: Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022;206:1434.
    PubMed    
    
    
    
33. HENRIQUES-NORMARK B, Narciso AR
    An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies.
    Am J Respir Crit Care Med. 2022;206:1312-1314.
    PubMed    
    
    
    
34. ROBINSON RE, Mitsi E, Nikolaou E, Pojar S, et al
    Human Infection Challenge with Serotype 3 Pneumococcus.
    Am J Respir Crit Care Med. 2022;206:1379-1392.
    PubMed     Abstract available
    
    
    November 2022
35. BEENTJES D, Shears RK, French N, Neill DR, et al
    Mechanistic Insights into the Impact of Air Pollution on Pneumococcal Pathogenesis and Transmission.
    Am J Respir Crit Care Med. 2022;206:1070-1080.
    PubMed     Abstract available
    
    
    October 2022
36. CHECKLEY W
    Tuberculosis, Wildfires, and Case-Crossover Studies: An Epidemiological Trifecta?
    Am J Respir Crit Care Med. 2022 Oct 31. doi: 10.1164/rccm.202210-1936.
    PubMed    
    
    
    September 2022
37. 
    Erratum: Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2022;206:800-801.
    PubMed    
    
    
    
38. LINDE LR, Readhead A, Barry PM, Balmes JR, et al
    Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California.
    Am J Respir Crit Care Med. 2022 Sep 14. doi: 10.1164/rccm.202203-0457.
    PubMed     Abstract available
    
    
    June 2022
39. MARAIS BJ, Graham SM
    The Value of Chest Radiography in Tuberculosis Preventive Treatment (TPT) Screening in Children and Adolescents.
    Am J Respir Crit Care Med. 2022 Jun 2. doi: 10.1164/rccm.202205-1023.
    PubMed    
    
    
    May 2022
40. DOWDY DW
    Coughing is Not Required to Transmit Mycobacterium tuberculosis: Another Nail in the Coffin.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202204-0645.
    PubMed    
    
    
    
41. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis.
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202202-0259.
    PubMed     Abstract available
    
    
    
42. DINKELE R, Gessner S, McKerry A, Leonard B, et al
    Aerosolization of Mycobacterium tuberculosis by Tidal Breathing.
    Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202110-2378.
    PubMed     Abstract available
    
    
    
43. TOBIN MJ
    Fiftieth Anniversary of Uncovering the Tuskegee Syphilis Study: The Story and Timeless Lessons.
    Am J Respir Crit Care Med. 2022;205:1145-1158.
    PubMed     Abstract available
    
    
    
44. DE JAGER V, Gupte N, Nunes S, Barnes GL, et al
    Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
    Am J Respir Crit Care Med. 2022;205:1228-1235.
    PubMed     Abstract available
    
    
    
45. ESMAIL A, Oelofse S, Lombard C, Perumal R, et al
    An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
    Am J Respir Crit Care Med. 2022;205:1214-1227.
    PubMed     Abstract available
    
    
    
46. OLIVIER KN, Prevots DR
    HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?
    Am J Respir Crit Care Med. 2022;205:982-983.
    PubMed    
    
    
    
47. GROSS JE, Caceres S, Poch K, Hasan NA, et al
    Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Am J Respir Crit Care Med. 2022;205:1064-1074.
    PubMed     Abstract available
    
    
    April 2022
48. SHAKU MT, Bishai WR
    Mycobacterium tuberculosis: A Pathogen That Can Hold its Breath a Long Time.
    Am J Respir Crit Care Med. 2022 Apr 20. doi: 10.1164/rccm.202203-0432.
    PubMed    
    
    
    
49. BUCSAN AN, Veatch A, Singh DK, Akter S, et al
    Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022 Apr 12. doi: 10.1164/rccm.202112-2747.
    PubMed     Abstract available
    
    
    
50. PITTET LF, Fritschi N, Tebruegge M, Dutta B, et al
    Bacillus Calmette-Guerin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2022;205:830-841.
    PubMed     Abstract available
    
    
    March 2022
51. LANGE C, Barry Iii CE, Horsburgh CR Jr
    Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel.
    Am J Respir Crit Care Med. 2022 Mar 23. doi: 10.1164/rccm.202202-0393.
    PubMed    
    
    
    February 2022
52. COOKSON W, Moffatt M, Rapeport G, Quint J, et al
    A Pandemic Lesson for Global Lung Diseases: Exacerbations are Preventable.
    Am J Respir Crit Care Med. 2022 Feb 22. doi: 10.1164/rccm.202110-2389.
    PubMed     Abstract available
    
    
    January 2022
53. SCHLUGER NW
    Of Mice and Men, Women, and Children: Using Animal Models to Inform Tuberculosis Clinical Trials of Novel Agents.
    Am J Respir Crit Care Med. 2022 Jan 31. doi: 10.1164/rccm.202112-2866.
    PubMed    
    
    
    
54. CHO HJ, Yu JH
    Quincke's Sign of Janeway Lesion in Infective Endocarditis.
    Am J Respir Crit Care Med. 2022 Jan 27. doi: 10.1164/rccm.202110-2362.
    PubMed    
    
    
    
55. O'DONNELL M, Mathema B
    Expanding the Tuberculosis Cascade of Care to Treat Undiagnosed and Subclinical Tuberculosis in High-Burden Settings.
    Am J Respir Crit Care Med. 2022;205:149-151.
    PubMed    
    
    
    December 2021
56. KAUSHIK A, Ammerman NC, Tasneen R, Lachau-Durand S, et al
    Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
    Am J Respir Crit Care Med. 2021 Dec 23. doi: 10.1164/rccm.202012-4541.
    PubMed     Abstract available
    
    
    
57. FENNELLY KP, Martinez L, Mandalakas AM
    Tuberculosis: First in Flight.
    Am J Respir Crit Care Med. 2021 Dec 14. doi: 10.1164/rccm.202111-2513.
    PubMed    
    
    
    
58. SHIMIZU T, Watanabe S, Murata A, Kasahara K, et al
    Bronchial Cast Hiding Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2021 Dec 3. doi: 10.1164/rccm.202105-1306.
    PubMed    
    
    
    
59. SCHLUGER NW
    Using Isoniazid More Safely and More Effectively: The Time Is Now.
    Am J Respir Crit Care Med. 2021;204:1248-1250.
    PubMed    
    
    
    
60. WATERS V
    Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations.
    Am J Respir Crit Care Med. 2021;204:1245-1247.
    PubMed    
    
    
    November 2021
61. BUNYASI EW, Middelkoop K, Koch A, Hoosen Z, et al
    Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools.
    Am J Respir Crit Care Med. 2021 Nov 9. doi: 10.1164/rccm.202102-0405.
    PubMed     Abstract available
    
    
    
62. ADJOBIMEY M, Behr MA, Menzies D
    Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity.
    Am J Respir Crit Care Med. 2021;204:1013-1014.
    PubMed    
    
    
    October 2021
63. ATRE SR, Jagtap JD, Faqih MI, Dumbare YK, et al
    Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202012-4333.
    PubMed     Abstract available
    
    
    
64. NOURSADEGHI M, Gupta RK
    New Insights into the Limitations of Host-Transcriptional Biomarkers of Tuberculosis.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202109-2146.
    PubMed    
    
    
    September 2021
65. LU S, Kolls JK
    Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model.
    Am J Respir Crit Care Med. 2021;204:626-627.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.